A randomized, open-label study of MabThera [rituximab] maintenance therapy compared with no further therapy after a brief induction with chemotherapy plus MabThera on failure-free survival in treatment-naive elderly patients with advanced follicular lymphoma.
Phase of Trial: Phase III
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Rituximab (Primary) ; Dexamethasone; Fludarabine; Mitoxantrone
- Indications Follicular lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 10 Jun 2017 Biomarkers information updated
- 19 Aug 2013 Results published in the Journal of Clinical Oncology.
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History